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Decoding the geneticblueprint is adream that
offersmanifold returns in termsofunderstand-
ing how organisms develop and function in an
often hostile environment. With the rapid
advances in molecular biology over the last 30
years, thedream has come astep closer to reali-
ty. Molecularbiologists nowhave theability to
elucidate the composition of any genome.
Indeed, almost 20 genomes have already been
sequenced and more than 60 are currently
under way. Foremost among these is the
Human Genome Mapping Project. However,
the genomes of a number ofcommonly used
laboratory species are also under intensive
investigation, including yeast, Arabidopsis,
maize, rice, zebra fish, mouse, rat, and dog. It
is widely expected that the completion ofsuch
programs will facilitate the development of
many powerful new techniques and approach-
es to diagnosing and treating genetically and
environmentally induced diseases which afflict
mankind. However, the vast amount ofdata
being generated by genome mapping will
require new high-throughput technologies to
investigate the function ofthe millions ofnew
genes that arebeingreported. Amongthe most
widely heralded of the new functional
genomics technologies are DNA arrays, which
represent perhaps the most anticipated new
molecular biology technique since polymerase
chain reaction (PCR).
Arrays enable the study ofliterally thou-
sands of genes in a single experiment. The
potential importance ofarrays is enormous and
has been highlighted by the recent publication
ofan entire Nature Geneticssupplement dedi-
cated to the technology (1). Despite this huge
surgeofinterest, DNAarrays arestill little used
and largely unproven, as demonstrated by the
high ratio ofreview and press articles to actual
data papers. Even so, the potential they offer
has driven venture capitalists into a frenzy of
investment and many new companies are
springing up to daim a share of this rapidly
developing market.
The U.S. Environmental Protection
Agency (EPA) is interested in applying DNA
array technology to ongoing toxicologic stud-
ies. To learn more about the current state of
the technology, the Reproductive Toxicology
Division (RTD) ofthe National Health and
Environmental Effects Research Laboratory
(NHEERL; Research Triangle Park, NC)
hosted a workshop on "Application of
Microarrays to Toxicology" on 7-8 January
1999 in Research Triangle Park, North
Carolina. The workshop was organized by
David Dix, Robert Kavlock, andJohn Rockett
of the RTD/NHEERL. Twenty-two intra-
mural and extramural scientists from govern-
ment, academia, and industry shared informa-
tion, data, and opinions on the current and
future applications for this exciting new tech-
nology. The workshop had more than 150
attendees, induding researchers, students, and
administrators from the EPA, the National
Institute ofEnvironmental Health Sciences
(NIEHS), and a number ofother establish-
ments from Research Triangle Park and
beyond. Presentations ranged from the tech-
nology behind array production through the
sharingofactual experimental dataand projec-
tions on the future importance and applica-
tions ofarrays. The information contained in
theworkshop presentations should provide aid
and insight into arrays in general and their
application totoxicologyinparticular.
Array Elements
In the context ofmolecular biology, theword
"array" is normally used to refer to a series of
DNA or protein elements firmly attached in
a regular pattern to some kind ofsupportive
medium. DNA array is often used inter-
changeably with gene array or microarray.
Although not formally defined, microarray is
generally used to describe the higher density
arrays typically printed on glass chips. The
DNA elements that make up DNA arrays
can be oligonucleotides, partial gene
sequences, or full-length cDNAs. Companies
offering pre-made arrays that contain less
than full-length dones normally use regions
ofthe genes which are specific to that gene to
prevent false positives arising through cross-
hybridization. Sequence verification of
cDNA clone identity is necessary because of
errors in identifying specific clones from
cDNA libraries and databases. Premade
DNA arrays printed on membranes are cur-
rently or imminently available for human,
mouse, and rat. In most cases they contain
DNA sequences representing several thou-
sand different sequence clusters or genes as
delineated through the National Center for
Biotechnology Information UniGene Project
(2). Manyofthesedifferent UniGene dusters
(putative genes) are represented only by
expressed sequence tags (ESTs).
Array Printing
Arrays are typically printed on one of two
types of support matrix. Nylon membranes
are used by most off-the-shelfarray providers
such as Clontech Laboratories, Inc.
(Palo Alto, CA), Genome Systems, Inc. (St.
Louis, MO), and Research Genetics, Inc.
(Huntsville, AL). Microarrays such as those
produced by Affymetrix, Inc. (Santa Clara,
CA), Incyte Pharmaceuticals, Inc. (Palo Alto,
CA), and many do-it-yourself (DIY) arraying
groups use glass wafers or slides. Although
standard microscope slides may be used, they
must be preprepared to facilitate sticking
of the DNA to the glass. Several different
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coatings have been successfully used, includ-
ing silane and lysine. The coating of slides
can easily be carried out in the laboratory,
but manyprefer the convenience ofprecoated
slides available from suppliers.
Once the support matrix has been pre-
pared, the DNA elements can be applied by
several methods. Affymetrix, Inc., has devel-
oped a unique photolithographic technology
for attaching oligonucleotides to glass wafers.
More commonly, DNA is applied by either
noncontact or contact printing. Noncontact
printers can usethermal, solenoid, orpiezoelec-
tric technology to spray aliquots ofsolution
onto the support matrix and may be used to
produce slide or membrane-based arrays.
Cartesian Technologies, Inc. (Irvine, CA) has
developed nQUAD technology for use in its
PixSys printers. The system couples a syringe
pump with the microsolenoid valve, a combi-
nation that provides rapid quantitative dispens-
ingofnanolitervolumes (down to 4.2 nL) over
a variable volume range. A different approach
to noncontactprintinguses asolidpinand ring
combination (Genetic MicroSystems, Inc.,
Wobum, MA). This system (Figure 1) allows a
broader range ofsample, indudingcell suspen-
sions and particulates, because the printing
head cannot be blocked up in the same way as
a spray nozzle. Fluid transfer is controlled in
this system primarily by the pin dimensions
and the force of deposition, although the
nature of the support matrix and the sample
willalsoaffecttransferto somedegree.
In contact printing, the pin head is dipped
in thesample andthen touched to thesupport
matrix to deposit a small aliquot. Split pins
were one ofthe first contact-printing devices
to be reported and are the suggested format
for DIY arrayers, as described by Brown (3).
Split pins are small metal pins with a precise
groove cut vertically in the middle ofthe pin
tip. In this system, 1-48 split pins are posi-
tioned in thepin-head. Thesplit pinsworkby
simple capillary action, not unlike a fountain
pen-when the pin heads are dipped in the
sample, liquid is drawn into the pin groove. A
small (fixed) volume is then deposited each
time the split pins are gently touched to
the support matrix. Sample (100-500 pL
depending on a variety ofparameters) can be
deposited on multiple slides before refilling is
required, and array densities of > 2,500
spots/cm2 maybe produced. The deposit vol-
ume depends on the split size, sample fluidi-
ty, and the speed ofprinting. Split pins are
relatively simple to produce and can be made
in-house if a suitable machine shop is avail-
able. Alternatively, they can be obtained
directly from companies such as TeleChem
International, Inc. (Sunnyvale, CA).
Irrespective of their source, printers
should be run through a preprint sequence
prior to producing the actual experimental
arrays; the first 100 or so spots ofa new run
tend to be somewhat variable. Factors effect-
ing spot reproducibility include slide treat-
ment homogeneity, sample differences, and
instrument errors. Other factors that come
into play include clean ejection of the drop
and clogging (nQUAD printing) and
mechanical variations and long-term alter-
ation in print-head surface ofsolid and split
pins. However, with careful preparation it is
possible to get a coefficient ofvariance for
spot reproducibilitybelow 10%.
One potential printing problem is sample
carryover. Repeated washing, blotting, and
drying (vacuum) ofprint pinsbetweensamples
is normally effective at reducing sample carry-
over to negligible amounts. Printing should
also be carried out in a controlled environ-
ment. Humidified chambers are available in
which to place printers. These help prevent
dust contamination and produce a uniform
drying rate, which is important in determining
spotsize, quality, andreproducibility.
In summary, although several printing
technologies are available, none are par-
ticularly outstanding and the bottom line
is that they are still in a relatively early stage
ofevolution.
Array Hybridization
The hybridization protocol is, practically
speaking, relatively straightforward and those
with previous experience in blotting should
have little difficulty. Array hybridizations
are, in essence, reverse Southern/Northern
blots-instead ofapplying a labeled probe to
the target population of DNA/RNA, the
labeled population is applied to the probe(s).
With membrane-based arrays, the control and
treated mRNA populations are normally con-
verted to cDNAand labeledwith isotope (e.g.,
33P) in the process. These labeled populations
are then hybridized independently to parallel
or serial arrays and the hybridization signal is
detected with a phosporimager. A less com-
monly used alternative to radioactive probes is
enzymatic detection. The probe may be
biotinylated, haptenylated, or have alkaline
phosphatase/horseradish peroxidase attached.
Hybridization is detected by enzymatic reac-
tion yielding a color reaction (4). Differences
in hybridization signals can be detected by eye
or, more accurately, with the help ofdigital
imaging and commercially available software.
The labeling ofthe test populations for slide-
based microarrays uses a slightly different
approach. The probe typically consists oftwo
samplesofpolyA+ RNA(usuallyfrom atreated
and acontrolpopulation) that areconverted to
cDNA; in the process each is labeled with a
different fluor. The independently labeled
probes are then mixed together and hybridized
to a single microarray slide and the resulting
combined fluorescent signal is scanned. After
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Figure 1. Genetic Microsystems (Woburn, MA) pin
ring system for printing arrays. The pin ring com-
bination consists of a circular open ring oriented
parallel to the sample solution, with a vertical pin
centered over the ring. When the ring is dipped
into a soution and lifted, it withdraws an aliquot
of sample held by surface tension. To spot the
sample, the pin is driven down through the ring
and a portion of the solution is transferred to the
bottom of the pin. The pin continues to move
downward until the pendant drop of solution
makes contact with the underlying surface. The
pin is then lifted, and gravity and surface tension
cause deposition of the spot onto the array.
Figure from Flowers et al. (14), with permission
from Genetic Microsystems.
normalization, it is possible to determine the
ratio of fluorescent signals from a single
hybridization ofaslide-based microarray.
cDNA derived from control and treated
populations of RNA is most commonly
hybridized to arrays, although subtractive
hybridization or differential display reactions
may also be used. Fluorophore- or radiola-
beled nucleotides are directly incorporated
into the cDNA in the process of converting
RNA to cDNA. Alternatively, 5' end-labeled
primers may be used for cDNA synthesis.
These are labeled with a fluorophore for
direct visualization of the hybridized array.
Alternatively, biotin or a hapten may be
attached to the primer, in which case fluor-
labeled streptavidin or antibody must be
applied before a signal can be generated. The
most commonly used fluorophores at present
are cyanine (Cy)3 and Cy5 (Amersham
Pharmacia Biotech AB, Uppsala, Sweden).
However, the relative expense of these fluo-
rescent conjugates has driven a search for
cheaper alternatives. Fluorescein, rhodamine,
and Texas red have all been used, and
companies such as Molecular Probes, Inc.
(Eugene, OR) are developing a series of
labeled nudeotides with awide range ofexci-
tation and emission spectrawhich may prove
to function aswell as the Cydyes.
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Ahalysis of DNA Microarrays
Membrane-based arrays are nornally analyzed
on film or with a phosphorimager, whereas
chip-based arrays require morespecalized scan-
ning devices. These can be divided into three
main groups: the arge-coupled device camera
systems, thenonconfocal laser scanners, and the
confocal laser scanners. Theadvantages anddis-
advantagesofeach system arelisted inTable 1.
Because a typical spot on a microarray can
contain > 108 molecules, it is dear that a large
variation in signal strength may occur.
Current scanners cannot work across this
manyorders ofmagnitude (4 or 5 is more typ-
ical). However, the scanning parameters can
normally be adjusted to collect more or less
signal, such that two orthree scans ofthe same
array should permit the detection of rare and
abundant genes.
When amicroarray isscanned, thefluores-
cent images are captured bysoftware normally
induded with the scanner. Several commercial
suppliers provide additional software for quan-
tifying array images, but the software tools are
constantly evolving to meet the developing
needs of researchers, and it is prudent to
define one's own needs and darify the exact
capabilities ofthe software before its purchase.
Issues that should be considered indude the
following
* Can thesoftwarelocate offsetspots?
* Can it quantitate across irregular hybridiza-
tion signals?
* Can the arrayed genes be programmed in for
easyidentification andlocation?
* Can the software connect via the Internet to
databases containing further information on
thegene(s) ofinterest?
One of the key issues raised at the work-
shop was the sensitivity ofmicroarray technol-
ogy. Experiments by General Scanning, Inc.
(Watertown, MA), have shown that by using
the Cy dyes and their scanner, signal can be
detected down to levels of < 1 fluor molecule
per square micrometer, which translates to
detecting a rare message at approximately one
copy per cell orless.
ArrayApplications
Although arrays are an emerging technology
certain to undergo improvement and
alteration, they have already been applied use-
fully to a number ofmodel systems. Arrays are
at their most powerfuil when they contain the
entire genome of the species they are being
used tostudy. Forthis reason, theyhave strong
support among researchers utilizing yeast and
Caenorhabditis elegans (5). The genomes of
both ofthesespecies have beensequenced and,
in the case of yeast, deposited onto arrays for
examination of gene expression (6,7). With
both of these species, it is relatively easy to
perturb individual gene expression. Indeed, C.
Table 1.Advantages and disadvantages ofdifferentmicroarrayscanning systems.
CCD camera system Nonconfocal laserscanner Confocal laserscanner
Advantages Fewmoving parts Relatively simple optics Small depth offocus reduces
artifacts
Fastscanning of bright - May have high lightcollection
samples efficiency
Disadvantages Less appropriatefordim Low lightcollection efficiency Small depth offocus requires
samples scanning precision
Optical scattercan limit Background artifacts notrejected
performance
Resolution typically low
CCD, charge-coupled device.
From Kawasaki (13).
elegans knockouts can be made simply by
soaking the worms in an antisense solution of
thegene to beknockedout.
By a process ofsystematic gene disrup-
tion, it is now possible to examine the cause
and effect relationships between different
genes in these simple organisms. This kind of
approach should help elucidate biochemical
pathways and genetic control processes,
deconvolute polygenic interactions, and
define thearchitecture ofthecellularnetwork.
A simple case study of how this can be
achieved was presented by Butow [University
of Texas Southwestern Medical Center,
Dallas, TX (Figure 2)]. Although it is the
phenotypic result ofa single gene knockout
that is being examined, the effect of such
perturbation will almost always be polygenic.
Polygenic interactions will become increasing-
ly important as researchers begin to move
away from single gene systems when examin-
ing the nature of toxicologic responses to
extemal stimuli. This is especially important
in toxicology because the phenotype pro-
duced by a given environmental insult is
never the result ofthe action ofa single gene;
rather, it is a complex interaction ofone or
multiple cellular pathways. Phenomena such
as quantitative trait (the continuous variation
ofphenotype), epistasis (the effect ofalleles of
one or more genes on the expression ofother
genes), and penetrance (proportion of indi-
viduals ofa given genotype thatdisplay a par-
ticular phenotype) will become increasingly
evident and important as toxicologists push
toward the ultimate goal of matching the
responses of individuals to different
environmental stimuli.
Analysis ofthe transcriptome (the expres-
sionlevelofall thegenes in agiven cellpopula-
tion) was a use ofarrays addressed by several
speakers. Unfortunately, current gene nomen-
clature is often confusing in that single genes
are allocated multiple names (usuallyas a result
ofindependent discoverybydifferent laborato-
ries), and therewas acall forstandardization of
gene nomendature. Nevertheless, once a tran-
scriptome has been assembled it can then be
transferred onto arrays and used to screen any
chosen system. The EPA MicroArray
Consortium (EPAMAC) is assembling testes
transcriptomes forhuman, rat, andmouse. In a
sligtly different approach, Nuwaysir et al. (8
describes how the NIEHS assembled what is
effectively a "toxicological transcriptome"-a
library ofhuman and mouse genes that have
previously been proven or implicated in
responses to toxicologic insults. Clontech
Laboratories, Inc. (PaloAlto, CA), has begun a
similar process by developing stress/toxicology
filter arrays ofrat, mouse, and human genes.
Thus, rather than being tissue or cell specific,
thesestress/toxicology arrays can be used across
a variety ofmodel systems to look for alter-
ations in the expression of toxicologically
important genes and define the new field of
toxicogenomics. The potential to identify toxi-
cant families based on tissue- or cell-specific
gene expression could revolutionize drug test-
ing. These molecular signatures or fingerprints
could not only point to the possible
toxicity/carcinogenicity ofnewly discovered
compounds (Figure3), butalsoaid in elucidat-
ingtheirmechanismofaction throughidentifi-
cation ofgene expression networks. By exten-
sion, such signatures could provide easily iden-
tifiable biomarkers to assess the degree, time,
andnatureofexposure.
DNA arrays are primarily a tool for exam-
ining differential gene expression in a given
model. In this context they are referred to as
dosed systems because they lack the ability of
other differential expression technologies, e.g.,
differential display and subtractive hybridiza-
tion, to detect previously unknown genes not
present on the array. This would appear to
limit the powerofDNAarrays to theimagina-
tions and preconceptions ofthe researcher in
selecting genes previously characterized and
thought to be involved in the model system.
However, the various genome sequencing pro-
jects have created a new category of
sequence-the EST-that has partially molli-
fied thisdeficiency. ESTs are cDNAs expressed
in a given tissue that, although they may share
somedegree ofsequence similaritytoprevious-
ly characterized genes, have not been assigned
specific genetic identity. By incorporating EST
dones into an array, it is possible to monitor
the expression ofthese unknown genes. This
can enable the identification of previously
uncharacterized genes that may have biologic
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significance in the model system. Filter arrays
from Research Genetics and slide arrays from
Incyte Pharmaceuticals both incorporate large
numbersofESTsfrom avarietyofspecies.
Afurther use ofmicroarrays is the identifi-
cation of single nucleotide polymorphisms
(SNPs). These genomic variations are abun-
dant-they occur approximately every 1 kb or
so-and are the basis ofrestriction fragment
length polymorphism analysis used in forensic
analysis. AflFmetrix, Inc., designed chips that
contain multiple repeats of the same gene
sequence. Each position is presentwith all four
possible bases. After the hybridization of the
sample, the degree ofhybridization to the dif-
ferent sequences can be measuredand the exact
sequence ofthe target gene deduced. SNPs are
thought to be of vital importance in drug
metabolism and toxicology. For example, sin-
gle base differences in the regulatory region or
active site of some genes can account for huge
differences in the activity of that gene. Such
SNPs are thought to explain why some people
are able to metabolize certain xenobiotics bet-
ter than others. Thus, arrays provide a firther
tool for the toxicologist investigating the
nature ofsusceptible subpopulations and toxi-
cologic response.
There are still many wrinkles to be ironed
out before arrays become a standard tool for
toxicologists. The main issues raised at the
workshop by those with hands-on experience
were thefollowing:
* Expense: the cost ofpurchasing/contracting
this technology is still too great for many
individual laboratories.
bh I--- -
* Clones: thelogistics ofidentifying, obtaining,
andmaintaining a setofnonredundant, non-
contaminated, sequence-verified, species/cell
tissue/field-specificdones.
* Use ofinbred strains: where whole-organism
models are being used, the use of inbred
strains is important to reduce the potentially
confusing effects ofthe individual variation
typically seen inoutbredpopulations.
* Probe: the need for relatively large amounts
of RNA, which limits the type of sample
(e.g., biopsy) that can be used. Also, different
RNA extraction methods can give different
results.
* Specificity: the ability to discriminate accu-
rately between dosely related genes (e.g., the
cytochromep450farnily) andsplicevariants.
* Quantitation: the quantitation of gene
expression using gene arrays is still open to
debate. One reason for this is the different
incorporation ofthe labeling dyes. However,
the main difficulty lies in knowing what to
normalize against. One option is to indude a
largenumberofso-calledhousekeeping genes
in the array. However, theexpression ofthese
genes often change depending on the tissue
and the toxicant, so it is necessary to charac-
terize the expression of these genes in the
model system before utilizing them. This is
clearly not a viable option when screening
multiple new compounds. A second option
is toindude on the array genesfrom a nonre-
lated species (e.g., a plant gene on an animal
array) and to spike the probe with synthetic
RNA(s) complementary to thegene(s).
* Reproducibility: this is sometimes question-
able, and a figure ofapproximately two or
three repeats was used as the minimum num-
ber required to confirm initial findings.
Again, however, most people advocated the
use ofNorthern blots or reverse tanscriptase
PCR toconfirmfindings.
* Sensitivity: concerns were voiced about the
numberoftargetmoleculesthat mustbe pre-
sent in a sample for them to be detected on
the array.
* Efficiency: reproducible identification of1.5-
to 2-folddifferences inexpression was report-
ed, although the number of genes that
undergo this level ofchange and remain
undetected is open to debate. It is important
that this level of detection be ultimately
achieved because it is commonly perceived
that some important transcription factors
and their regulators respond at such low lev-
els. In most cases, 3- to 5-fold was the mini-
mum change that most were happy to
accept.
* Bioinformatics: perhaps the greatest concern
was how to accurately interpret the datawith
the greatest accuracy and efficiency. The
biggest headache is trying to identify net-
worksofgeneexpression that are common to
different treatments ordoses. The amountof
datafrom asingleexperiment ishuge. It may
be that, in the future, several groups individ-
uallyequippedwithspecializedsoftwarealgo-
rithms for studying their favorite genes or
gene systems will be able to share the same
hybridized chips. Thus, arrays could usher in
a new perspective on collaboration and the
sharingofdata
EPAMAC
Perhaps the main reason most scientists are
unable to use arraytechnology is thehigh cost
involved, whether buying off-the-shelf mem-
branes, using contract printing services, or
E~
Figur 2. Potential effects of gene knockout within
positively and negatively regulated gene expression
networks. il is limiting in wild type for expression of
i2. (A) A simple, two-component, linear regulatory
network operating on gene i1, whereil is a positive
effector of ,2 and i,, is either a positive or negative
effector of il. This network could be deduced by
examining the consequence of(B) deletingj,i onthe
expression of il and i2, where the expression of i2
would be decreased or increased depending on
whether j,i was a positive or negative regulator.
These and other connected components of even
greater complexity could be revealed by genome-
wide expression analysis. From Butow(15).
Test compound 1
Test compound 2
Endocrine disruptors
Toxicant family Heavy metals
Oxidant soressors
Peroxisome proliferators
Polycyclic aromatic hydrocarbons
c D
Figure 3. Gene expression profiles-also called fingerprints or signatures-of known toxicants or toxi-
cant families may, in the future, be used to identify the potential toxicity of new drugs, etc. In this exam-
ple, the genetic signature of test compound 1 is identical to that of known peroxisome proliferators.
whereas that oftest compound 2 does not match any known toxicantfamily. Based on these results, test
compound 2would be retained forfurthertesting and test compound 1 would be eliminated.
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producing chips in-house. In view of this,
researchers at the RTD/NHEERL initiated
the EPAMAC. This consortium brings
together scientists from the EPA and a num-
ber ofextramural labs with the aim ofdevel-
oping microarray capability through the shar-
ing of resources and data. EPAMAC
researchers are primarily interested in the
developmental and toxicologic changes seen
in testicular and breast tissue, and a portion
of the workshop was set aside for EPAMAC
members to share their ideas on how the
experimental application ofmicroarrays could
facilitate their research. One of the central
areas ofinterest to EPAMAC members is the
effect of xenobiotics on male fertility and
reproductive health. Of greatest concern is
the effect ofexposure during critical periods
ofdevelopment and germ cell differentiation
(9), and how this may compromise sperm
counts and quality following sexual matura-
tion (10). As well as spermatogenic tissue,
there is also interest in how residual mRNA
found in mature sperm (11) could be used as
an indicator ofprevious xenobiotic effects (it
is easier to obtain a semen sample than a tes-
ticularbiopsy). Arrayswill be used to examine
and compare the effect of exposure to heat
and chemicals in testicular and epididymal
gene expression profiles, with the aim of
establishing relationships/associations
between changes in developmental landmarks
and the effects on sperm count and quality.
Cluster, pattern, and other analysis of such
data should help identifyhidden relationships
between genes that may reveal potential
mechanisms of action and uncover roles for
geneswith unknown functions.
Summary
The full impact of DNA arrays may not be
seen for several years, but the interest shown at
this regional workshop indicates the high level
ofinterest that they foster. Apart from educat-
ing and advertising the various technologies in
this field, this workshop brought together a
number of researchers from the Research
Triangle Parkareawho are already using DNA
arrays. The interest insharing ideas andexperi-
ences led to the initiation of a Triangle array
usersgroup.
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Array technology is still in its infancy. This
means that the hardware is still improving and
there is no current consensus for standard pro-
cedures, quantitation, and interpretation.
Consistency in spotting and scanning arrays is
not yet optimized, and this is one ofthe most
critical requirements of any experiment. In
addition, one ofthe dark regions ofarray tech-
nology-strife in the courts over who owns
what portions ofit-has further muddled the
future and is a potential barrier toward the
development ofconsensus procedures.
Perhaps the greatest hurdle for the applica-
tion ofarrays is the actual interpretation of
data. No specialists in bioinformatics attended
theworkshop, largelybecause they are rare and
because as yet no one seems dear on the best
methodofapproachingdataanalysis and inter-
pretation. Cross-referencing results from mul-
tiple experiments (time, dose, repeats, different
animals, different species) toidentifycommon-
ly expressed genes is a great challenge. In most
cases, we are still a long way from understand-
ing how the expression ofgene Xis related to
the expression ofgene lK and ordering gene
expression to delineate causal relationships.
To the ordinaryscientist in the typicallab-
oratory, however, the most immediate prob-
lem is a lack of affordable instrumentation.
One can purchase premade membranes at
relatively affordable prices. Although these
may be useful in identifying individual genes
to pursue in more detail using other methods,
the numbers thatwould be required foreven a
small routine toxicology experiment prohibit
this as atrulyviable approach. For the toxicol-
ogist, there is a need to carry out multiple
experiments-dose responses, time curves,
multiple animals, and repeats. Glass-based
DNA arrays are most attractive in this context
because they can be prepared in large batches
from the same DNA source and accommo-
date control and treated samples on the same
chip. Another problem with current off-the-
shelfarrays is that they often do not contain
one or more ofthe particular genes a group is
interested in. One alternative is to obtain
and/or produce a set of custom clones and
have contract printing ofmembranes or slides
carried out by a company such as Genomic
Solutions, Inc. (AnnArbor, MI).Thisapproach
is less expensive than laying out capital for
one's own entire system, although at some
point it might make economic sense to print
ones own arrays.
Finally, DNA arrays are currently a team
effort. They are a technology that uses a wide
range ofskills including engineering, statistics,
molecular biology, chemistry, and bioinfor-
matics. Because most individuals are skilled in
only one or perhaps two of these areas, it
appears that success with arrays may be best
expected by teams ofcollaborators consisting
ofindividuals havingeachoftheseskills.
Those considering array applications may
be amused or goaded on by the following
quote from Fortunemagazine (12):
Microprocessors have reshaped our economy,
spawnedvastfortunes andchanged thewaywelive.
Genechipscouldbeeven bigger.
Although this comment may have been
designed to excite the imagination rather than
accurately reflect the truth, it is fair to say that
the age of functional genomics is upon us.
DNAarrays looksetto be an important tool in
this new age ofbiotechnology and will likely
contribute answers to some of toxicology's
mostfundamental questions.
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